CDKN2A and neoplasm: We identified 31 amplified segments in the primary tumors, which harbored several known oncogenes including CCND1, TERT, and MYC. We also identified 16 lost segments in the primary tumors, which harbored tumor suppressors including TP53 (17p13), RB1 (13q14), and CDKN2A (9q21).